Botox drug maker Allergan has secured an injunction against a Sydney-based cosmetics company which sought to āleverageā the reputation of the well-known injectable to sell its Freezeframe line of anti-aging topical creams.
Australian rock band Little River Band has secured an injunction against an Adelaide-based record label accused of hijacking the bandās Spotify accounts on behalf of disgruntled former band members.
Danish drug maker Lundbeck has told the High Court it did not contract away a royalty-free licence to generic drug maker Sandoz to sell blockbuster antidepressant Lexapro, saying such a decision would be commercial āmadnessā.
In a victory for Tradie briefs manufacturer Sojo, a delegate has shot down clothing start-up Rebel Power’s bid to trade mark the words ‘shit hot tradie’.
The a2 Milk Company has reached a settlement in its fight against New Zealand-based Open Country’s trade mark containing the jealously guarded ‘a2’, with the rival dairy supplier dropping its successful application to register the mark.
Apple has been hit with a lawsuit alleging iPhone and iPad devices sold in Australia since at least 2014 and equipped with Touch and Face ID technology infringe two patents held by a non-practicing entity.
Pharmaceutical giants Merck Sharpe & Dohme and Pfizer have resolved a long-running intellectual property dispute over a 2015 patent owned by Pfizer for a pneumococcal vaccine.
US singer Katy Perry can withdraw an admission in a trade mark infringement case that licensing her brand to Target and Myer constituted use, with a judge finding the admission was ānot consistent with current lawā.
The Federal Court’s decision that artificial intelligence can be listed on a patent application as the inventor has become an outlier, as the UK joins the US in rejecting what has become an international battle to claim AI inventorship.
An Australian generic drug manufacturer has struck back at patent lawsuit by Swiss pharmaceutical company Biogen, alleging a patent for MS drug Tecfidera is invalid and a that a patent term extension for the drugĀ was wrongly granted.